logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutCareersContact UsSecurity
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Class
    3. Histamine-1 Receptor Antagonist

    Histamine-1 Receptor Antagonist class drugs

    FiltersReset Filters
    10 results

    • azelastine hydrochloride

      (Azelastine)
      Medication Details
      AvKARE
      Usage: Azelastine hydrochloride nasal spray, 0.1%, is indicated for treating symptoms of seasonal allergic rhinitis in individuals 5 years and older, and for vasomotor rhinitis in those 12 years and older.
      Medication Details
      Drug Interactions

    • bepreve

      (bepotastine besilate)
      Medication Details
      Bausch & Lomb Incorporated
      Usage: BEPREVE® (bepotastine besilate ophthalmic solution) 1.5% is indicated for treating itching linked to allergic conjunctivitis symptoms.
      Medication Details
      Drug Interactions

    • carbinoxamine maleate

      (CARBINOXAMINE MALEATE)
      Medication Details
      BluCrest Pharmaceuticals, LLC
      Usage: Carbinoxamine maleate is indicated for the symptomatic treatment of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin manifestations, dermatographism, and as an adjunctive therapy for anaphylactic reactions and allergic reactions to blood or plasma.
      Medication Details
      Drug Interactions

    • carbinoxamine maleate

      (Carbinoxamine Maleate)
      Medication Details
      Biocomp Pharma, Inc.
      Usage: Carbinoxamine maleate is indicated for the symptomatic treatment of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin conditions, dermatographism, as adjunct therapy for anaphylactic reactions, and to reduce the severity of allergic reactions to blood or plasma.
      Medication Details
      Drug Interactions

    • cetirizine hydrochloride

      (CETIRIZINE HYDROCHLORIDE)
      Medication Details
      Rising Pharma Holdings, Inc.
      Usage: Cetirizine hydrochloride oral solution is indicated for treating uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged 6 months to 5 years, significantly reducing the occurrence, severity, and duration of hives and alleviating itching.
      Medication Details
      Drug Interactions

    • cetirizine hydrochloride oral solution

      (Cetirizine Hydrochloride Oral Solution)
      Medication Details
      APOZEAL PHARMACEUTICALS INC
      Usage: Cetirizine Hydrochloride Oral Solution is indicated for relieving symptoms of perennial allergic rhinitis in children 6 to 23 months and treating chronic idiopathic urticaria in children 6 months to 5 years, effectively reducing sneezing, nasal and ocular symptoms, and hive-related discomfort.
      Medication Details
      Drug Interactions

    • desloratadine

      (DESLORATADINE)
      Medication Details
      Lupin Pharmaceuticals, Inc.
      Usage: Desloratadine tablets are indicated for relieving nasal and non-nasal symptoms of seasonal and perennial allergic rhinitis in patients aged 12 and older.
      Medication Details
      Drug Interactions

    • dymista

      (Azelastine Hydrochloride and Fluticasone Propionate)
      Medication Details
      Meda Pharmaceuticals Inc.
      Usage: DYMISTA is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and children aged 6 years and older.
      Medication Details
      Drug Interactions

    • levocetirizine dihydrochloride

      (levocetirizine dihydrochloride)
      Medication Details
      Glenmark Pharmaceuticals Inc., USA
      Usage: Levocetirizine dihydrochloride is indicated for relieving symptoms of perennial allergic rhinitis in children aged 6 months to 2 years and for treating uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months and older.
      Medication Details
      Drug Interactions

    • levocetirizine dihydrochloride

      (Levocetirizine dihydrochloride)
      Medication Details
      Padagis Israel Pharmaceuticals Ltd
      Usage: Levocetirizine dihydrochloride is indicated for relieving symptoms of perennial allergic rhinitis in children aged 6 months to 2 years and for treating uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children aged 6 months and older.
      Medication Details
      Drug Interactions